96 related articles for article (PubMed ID: 2785904)
21. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
Zhao WH; Asano N; Hu ZQ; Shimamura T
J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
[TBL] [Abstract][Full Text] [Related]
22. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
[TBL] [Abstract][Full Text] [Related]
23. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
Stapleton P; Shannon K; Phillips I
J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
[TBL] [Abstract][Full Text] [Related]
24. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
Richmond MH
Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
[TBL] [Abstract][Full Text] [Related]
25. β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates.
Agrawal GN; Rahangdale HD; Walawalkar AW
Indian J Pathol Microbiol; 2017; 60(1):142-143. PubMed ID: 28195120
[No Abstract] [Full Text] [Related]
26. [Clinical and laboratory significance of inducible beta-lactamases].
Bedenić B; Zagar Z
Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
[TBL] [Abstract][Full Text] [Related]
27. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
28. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
Brown J; Yang YJ; Livermore DM
J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Bujdáková H; Kallová J; Lausová A; Kettner M
Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
[TBL] [Abstract][Full Text] [Related]
30. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
31. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain.
Colom K; Fernández-Aranguiz A; Alonso R; Suinaga E; Cisterna R
Microb Drug Resist; 1996; 2(3):353-9. PubMed ID: 9158795
[TBL] [Abstract][Full Text] [Related]
32. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
[TBL] [Abstract][Full Text] [Related]
33. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
34. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
Acar JF; Minozzi C
Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
[TBL] [Abstract][Full Text] [Related]
35. Selection frequency of resistant variants by various beta-lactam antibiotics in clinical Enterobacter cloacae isolates.
Büscher KH; Cullmann W; Dick W; Stieglitz M
Chemotherapy; 1987; 33(1):40-51. PubMed ID: 3493886
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors.
Sawai T; Yamaguchi A
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):121S-129S. PubMed ID: 2591172
[TBL] [Abstract][Full Text] [Related]
37. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
39. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
Nagy E; Szóke I; Gacs M; Csiszár K
Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
[TBL] [Abstract][Full Text] [Related]
40. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Moritz VA; Carson PB
J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
